Lawrence D. Longo MD Center for Perinatal Biology, Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA, USA.
J Physiol. 2023 Apr;601(8):1501-1514. doi: 10.1113/JP284336. Epub 2023 Mar 15.
Hypoxia during pregnancy impairs uterine vascular adaptation via microRNA-210 (miR-210)-mediated mitochondrial dysfunction and mitochondrial reactive oxygen species (mtROS) generation. TET methylcytosine dioxygenase 2 (TET2) participates in regulating inflammation and oxidative stress and its deficiency contributes to the pathogenesis of multiple cardiovascular diseases. Thus, we hypothesize a role of TET2 in hypoxia/miR-210-mediated mtROS suppressing spontaneous transient outward currents (STOCs) in uterine arteries. We found that gestational hypoxia downregulated TET2 in uterine arteries of pregnant sheep and TET2 was a target of miR-210. Knockdown of TET2 with small interfering RNAs suppressed mitochondrial respiration, increased mtROS, inhibited STOCs and elevated myogenic tone. By contrast, overexpression of TET2 negated hypoxia- and miR-210-induced mtROS. The effects of TET2 knockdown in uterine arteries on mtROS, STOCs and myogenic contractions were blocked by the mitochondria-targeted antioxidant MitoQ. In addition, the recovery effects of inhibiting endogenous miR-210 with miR-210-LNA on hypoxia-induced suppression of STOCs and augmentation of myogenic tone were reversed by TET2 knockdown in uterine arteries. Together, our study reveals a novel mechanistic link between the miR-210-TET2-mtROS pathway and inhibition of STOCs and provides new insights into the understanding of uterine vascular maladaptation in pregnancy complications associated with gestational hypoxia. KEY POINTS: Gestational hypoxia downregulates TET methylcytosine dioxygenase 2 (TET2) in uterine arteries of pregnant sheep. TET2 is a downstream target of microRNA-210 (miR-210) and miR-210 mediates hypoxia-induced TET2 downregulation. Knockdown of TET2 in uterine arteries recapitulates the effect of hypoxia and miR-210 and impairs mitochondrial bioenergetics and increases mitochondrial reactive oxygen species (mtROS) . Overexpression of TET2 negates the effect of hypoxia and miR-210 on increasing mtROS. TET2 knockdown reiterates the effect of hypoxia and miR-210 and suppresses spontaneous transient outward currents (STOCs) and elevates myogenic tone, and these effects are blocked by MitoQ. Knockdown of TET2 reverses the miR-210-LNA-induced reversal of the effects of hypoxia on STOCs and myogenic tone in uterine arteries.
怀孕期间的缺氧会通过 microRNA-210(miR-210)介导的线粒体功能障碍和线粒体活性氧(mtROS)生成来损害子宫血管的适应性。TET 甲基胞嘧啶双加氧酶 2(TET2)参与调节炎症和氧化应激,其缺乏导致多种心血管疾病的发病机制。因此,我们假设 TET2 在缺氧/miR-210 介导的 mtROS 抑制子宫动脉自发瞬时外向电流(STOCs)中发挥作用。我们发现,妊娠期间的缺氧会下调怀孕绵羊子宫动脉中的 TET2,而 TET2 是 miR-210 的靶标。用小干扰 RNA 敲低 TET2 会抑制线粒体呼吸,增加 mtROS,抑制 STOCs 并升高血管平滑肌张力。相比之下,TET2 的过表达会消除缺氧和 miR-210 诱导的 mtROS。线粒体靶向抗氧化剂 MitoQ 可阻断子宫动脉中 TET2 敲低对 mtROS、STOCs 和血管平滑肌张力的影响。此外,用 miR-210-LNA 抑制内源性 miR-210 对缺氧诱导的 STOCs 抑制和血管平滑肌张力增加的恢复作用,可被子宫动脉中的 TET2 敲低逆转。综上所述,我们的研究揭示了 miR-210-TET2-mtROS 通路与 STOCs 抑制之间的新机制联系,并为理解与妊娠期间缺氧相关的妊娠并发症中子宫血管适应不良提供了新的见解。
妊娠期间的缺氧会下调怀孕绵羊子宫动脉中的 TET 甲基胞嘧啶双加氧酶 2(TET2)。
TET2 是 microRNA-210(miR-210)的下游靶标,miR-210 介导缺氧诱导的 TET2 下调。
子宫动脉中的 TET2 敲低可重现缺氧和 miR-210 的作用,并损害线粒体生物能学并增加线粒体活性氧(mtROS)。
TET2 的过表达可消除缺氧和 miR-210 对增加 mtROS 的作用。
TET2 敲低可重复缺氧和 miR-210 的作用,并抑制自发瞬时外向电流(STOCs)并升高血管平滑肌张力,这些作用可被 MitoQ 阻断。
子宫动脉中的 TET2 敲低可逆转 miR-210-LNA 诱导的缺氧对 STOCs 和血管平滑肌张力的作用逆转。